Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis

• Nicole Trepanowski, MD,
• Rebecca M. Yim, BA,
• Rachel Wetstone, MPH,
• Elizabeth MacDonald, BS,
• Sarah Servattalab, MD,
• Subin Jacob-George, PA,
• John E. Harris, MD, PhD

Affiliations

Nicole Trepanowski, MD

Boston University School of Medicine, Boston, Massachusetts; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts

Rebecca M. Yim, BA

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Tulane University School of Medicine, Tulane, Louisiana

Rachel Wetstone, MPH

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Florida International University College of Medicine, Herbert Wertheim College of Medicine, Miami, Florida

Elizabeth MacDonald, BS

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts

Sarah Servattalab, MD

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts

Subin Jacob-George, PA

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts

John E. Harris, MD, PhD

Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts; Correspondence to: John E. Harris, MD, PhD, Department of Dermatology, University of Massachusetts Chan Medical School, 364 Plantation Street, LRB 1010, Worcester, MA 01605.